Filter
1499
Text search:
Antiretroviral
therapy
(ART)
Featured
130
490
Language
Document type
1008
184
159
43
29
28
26
7
5
3
2
1
1
Countries / Regions
71
66
59
58
55
51
43
38
35
33
32
27
25
24
23
23
20
19
17
16
16
15
14
14
12
12
11
11
11
10
8
7
7
6
6
6
5
5
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
750
111
52
34
30
25
8
1
Toolboxes
439
193
31
18
17
13
11
11
9
9
8
7
7
6
5
5
4
4
4
3
3
1
1
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex G Abstract
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment.
Topics in Antiviral Medicine, March 4, 2025
CDC leads an international surveillance effort to estimate the occurrence of HIV drug resistance among people with HIV who are taking dolutegravir (DTG)-based treatments. This surveillance effort utilizes Cyclical Acquired HIV Drug Resistance Surveillance (CADRE), a laboratory-based HIV drug resista
...
During ARV drug pressure the HIV-1 RT is able to develop resistance to these drugs by generating mutations
ATIC Newsletter, Vol 15, Issue 1,
February 2022.
СТАНДАРТ МЕДИЧНОЇ ДОПОМОГИ.
These clinical guidelines, released by the Ukraine Ministry of Health in 2025, include the latest recommendations for HIV services, including oral PrEP and injectable cabotegravir (CAB) for PrEP.
what lessons can we take from the last few decades of health behaviour change efforts as we enter the era of HIV prevention pills, rings and injections?
These 2025 guidelines respond to the need for better approaches to identify advanced HIV disease, improve the poor outcomes of people living with HIV being discharged from hospital and provide updated guidance for treatment for Kaposi’s sarcoma through evidence-informed recommendations. The public
...
JAMA. 2025;333(7):609–628. doi:10.1001/jama.2024.24543
Dosing of LPV/r by formulation & dose modification (RTV super-boosting/double-dose LPV/r) for children receiving rifampicin-containing TB treatment. Chart
The emergence of high-level dolutegravir resistance was extremely rare in people switched to first-line dolutegravir-based treatment in Zambia and Malawi, a large prospective study has found.
Modelling shows that it will be essential to complement lenacapavir with additional prevention options, testing and treatment. See “Meeting reports” at https://www.unaids.org/en/resources/publications/all for a description of models and tools to estimate potential impact and quantifications requ
...
Southern African Journal of HIV Medicine
This guideline document is a publication of the National AIDS & STI Control Program, Ministry of Health
Kenya
A Guide for Community Case Workers in OVC Programs. This guide is meant to help you, a community case worker or
facility case manager working on an orphans and vulnerable children (OVC) program, to understand your role in supporting
multi-month dispensing (MMD) of anti-retroviral (ARV) medicines f
...
Oral PrEP Tool app
recommended
The WHO PrEP Implementation Tool app for health workers
Download IOS
Download play store
This eLearning course is for practicing health professionals around the globe who currently have a client population at high-risk for contracting HIV and provide or will provide Oral PrEP or Post-Exposure Prophylaxis (PEP). The course has four interactive lessons and begins with identifying suitable
...
Este curso introduce la prevención combinada del VIH y la PrEP (profilaxis preexposición), brindando herramientas técnicas para su correcta implementación y seguimiento en la región.
This course introduces combined HIV prevention and PrEP (pre-exposure prophylaxis), providing technical tools for its proper implementation and monitoring in the region.
